StonvexLoading…
StonvexCore line items from IDA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-29 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|---|
Revenue | $521.34M | $1.75B | $1.39B | $860.46M | $411.14M |
Operating Income | Not available | $353.98M | $300.32M | $155.50M | $54.93M |
Net Income | Not available | $323.47M | $279.87M | $155.43M | $59.65M |
EPS (Diluted) | $1.82 | $5.90 | $5.13 | $2.87 | $1.10 |
Total Assets | Not available | $10.23B | $10.08B | $9.94B | $9.59B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $215.72M | $333.21M | $474.49M | $634.50M |
Free Cash Flow OCF − CapEx | Not available | $-577.49M | $-361.29M | $-233.40M | $-77.04M |
Shares Outstanding | Not available | 54.81M | 54.52M | 54.25M | 54.13M |